|Bid||17.950 x 100|
|Ask||18.000 x 200|
|Day's Range||17.600 - 18.000|
|52 Week Range||9.660 - 19.900|
|PE Ratio (TTM)||-42.99|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Mylan stock fell as the FDA is looking for more information into its generic version of the multiple sclerosis drug Copaxone.
Momenta Pharmaceuticals (MNTA) needs Investors to pay close attention to the stock based on moves in the options market lately.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Momenta Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to MNTA-US. Comparing the performance and risk of Momenta Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)